PF-04958242
Sponsors
Biogen
Conditions
Cognitive Impairment Associated With Schizophrenia (CIAS)HealthyHealthy VolunteerHealthy VolunteersHearing Loss, SensorineuralSchizophrenia
Phase 1
First-in-Human Study of PF-04958242 in Healthy Volunteers
CompletedNCT01159483
Start: 2010-07-15End: 2010-10-16Updated: 2019-12-24
Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PF-04958242 in Healthy Adult Volunteers
TerminatedNCT01238679
Start: 2010-11-24End: 2011-05-03Updated: 2019-12-24
A Study To Assess Effects Of PF-04958242 On Bold Functional Magnetic Resonance Imaging During Working Memory Activation And Arterial Spin Labeling At Rest In Healthy Subjects
CompletedNCT01365338
Start: 2011-06-24End: 2012-12-14Updated: 2019-12-24
Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Repeated Doses of PF-04958242 in Healthy Volunteers
CompletedNCT01511510
Start: 2011-06-30End: 2011-11-30Updated: 2019-11-21
A Study To Examine The Safety, Tolerability And Pharmacokinetics Of PF-04958242 In Psychiatrically Stable Subjects With Schizophrenia
CompletedNCT01518894
Start: 2011-11-30End: 2012-03-31Updated: 2019-11-21
A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss
CompletedNCT01518920
Start: 2011-12-31End: 2013-02-28Updated: 2019-11-21
A Study To Examine The Effects Of PF-04958242 On Ketamine-Induced Cognitive Impairment In Healthy Volunteers
CompletedNCT01749098
Start: 2012-12-31End: 2014-02-28Updated: 2019-11-21
Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-04958242 In Healthy Volunteers
CompletedNCT02228395
Start: 2014-09-22End: 2014-11-13Updated: 2020-01-07
Multiple Ascending Doses of PF-04958242 in Subjects With Stable Schizophrenia
CompletedNCT02332798
Start: 2015-01-06End: 2015-04-15Updated: 2021-10-25
A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of PF-04958242 in Healthy Subjects
CompletedNCT02341482
Start: 2015-02-05End: 2015-03-31Updated: 2020-01-09